Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2023 Earnings Call Transcript May 4, 2023
Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2023 Financial Business Results Conference Call. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors, Investor Relations for Protalix. You may now begin.
Charles Padala: Thank you, Tina. Welcome, everyone, to the Protalix...
